iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Natco Pharma consolidated net profit rises 327.20% in the June 2022 quarter

9 Aug 2022 , 03:33 PM

Net profit of Natco Pharma rose 327.20% to Rs 320.40 crore in the quarter ended June 2022 as against Rs 75.00 crore during the previous quarter ended June 2021. Sales rose 115.60% to Rs 884.60 crore in the quarter ended June 2022 as against Rs 410.30 crore during the previous quarter ended June 2021.

Particulars Quarter Ended
? Jun. 2022 Jun. 2021 % Var.
Sales 884.60 410.30 116
OPM % 44.69 26.76
PBDT 425.40 124.80 241
PBT 385.80 91.00 324
NP 320.40 75.00 327

Powered by Capital Market – Live News

Related Tags

  • capital market
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.